Researchers
-
Alba Oliveras
Cardiovascular clinical research
-
Anna Contra Carne
Cardiovascular clinical research
-
Antonio Carol Ruiz
Cardiovascular clinical research
-
Antonia Ortega Díaz
Cardiovascular clinical research
-
Carlos Enrique Sabbagh Fajardo
Cardiovascular clinical research
-
carmen martin
Cardiovascular clinical research
-
Elizabeth Mena Sebastià
Cardiovascular clinical research
-
Joan Pol Monteys Montblanch
Cardiovascular clinical research
-
José Navarrete Monte
Cardiovascular clinical research
-
Maria Del Señor Cortés Fernández
Cardiovascular clinical research
-
Marta Camprecios Crespo
Cardiovascular clinical research
-
Mercè Faraudo
Cardiovascular clinical research
-
Miriam Garcia Bermudez
Cardiovascular clinical research
-
Olga Guri
Cardiovascular clinical research
-
Peter Castellanos
Cardiovascular clinical research
-
Pilar Sánchez Chamero
Cardiovascular clinical research
Phd -
Raúl Lafuente Masqueda
Cardiovascular clinical research
-
Román Freixa Pamías
Cardiovascular clinical research
Phd -
Sandra Lara Sanmartin
Cardiovascular clinical research
Contact the group
Form
Projects
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Risk factors associated with the progression of heart failure (HF) in patients with atrial fibrillation treated with a direct oral anticoagulant (rivaroxaban),
-
DISTRICT ATTORNEY:
BAYER HISPANIA, SL,
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Randomized, parallel-group, placebo-controlled, double-blind, multicenter trial to evaluate the efficacy and safety of the oral GCs stimulator vericiguat in improving physical performance in daily activities in patients with heart failure and preserved ejection fraction,
-
DISTRICT ATTORNEY:
Bayer AG
-
TYPE E:
RD2015
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Confirm Rx™ Insertable Heart Monitor SMART Record
-
DISTRICT ATTORNEY:
Abbott Medical Spain SA
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Randomized comparison between invasive and conservative strategies in frail elderly patients with non-ST-segment elevation myocardial infarction (MOSCA-FRAIL),
-
DISTRICT ATTORNEY:
Spanish Society of Cardiology
-
TYPE E:
PINE TREE
-
- Year 2018
- Comprehensive Care Center Dos de Maig Hospital
Prognostic determinants of mortality and readmission in patients with Advanced Heart Failure (HF) treated in Primary Care: HADES study,
-
DISTRICT ATTORNEY:
Jordi Gol University Institute for Primary Care Research (IDIAP)
-
TYPE E:
PINE TREE
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Study of satisfaction of the circuit prior to the programmed electrical cardioversion performed in a day hospital and of the impact of the information on the success of the procedure,
-
DISTRICT ATTORNEY:
Mrs. Antonia Ortega Díaz
-
TYPE E:
PINE TREE
-
Cardiovascular clinical research
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Non-interventionist study on edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation,
-
DISTRICT ATTORNEY:
Daiichi Sankyo Europe GmbH
-
TYPE E:
EPA
-
Cardiovascular clinical research
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Intervention to reduce symptoms of anxiety and depression in cardiac patients in a cardiac rehabilitation program,
-
DISTRICT ATTORNEY:
Institute of Education Sciences - Mr. Anthony Sans Martin
-
TYPE E:
PI
-
Cardiovascular clinical research
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional, cross-sectional study to describe NOACs management in patients with non-valvular atrial fibrillation (NVAF) in Spain. RE-KNOCE Study,
-
DISTRICT ATTORNEY:
Boehringer Ingelheim España SA
-
TYPE E:
EPA
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Non-interventionist study on edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation,
-
DISTRICT ATTORNEY:
Daiichi Sankyo Europe GmbH
-
TYPE E:
EPA
Lines of action
- Self control in carriers Mechanical prosthesis
- Cryptogenetic stroke
- Spontaneous coronary dissection
- Atrial fibrillation, anticoagulation and stroke / bleeding
- Integrated cardiology primary care
- LDL control in post-SCA patients
- Impact of IC Functional Unit on Hospital Admissions / Re-admissions
